Keay Nakae
Stock Analyst at Chardan Capital
(3.43)
# 2,399
Out of 4,604 analysts
607
Total ratings
39.8%
Success rate
3%
Average return
Main Sectors:
Stocks Rated by Keay Nakae
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARWR Arrowhead Pharmaceuticals | Maintained: Buy | $115 | $86.91 | +32.32% | 49 | Aug 4, 2026 | |
| STOK Stoke Therapeutics | Maintained: Buy | $35 | $31.93 | +9.61% | 2 | Aug 3, 2026 | |
| DYN Dyne Therapeutics | Maintained: Buy | $38 | $26.17 | +45.20% | 18 | Jul 29, 2026 | |
| PMN ProMIS Neurosciences | Initiated Coverage: Buy | $20 | $13.48 | +48.37% | 1 | Jul 26, 2026 | |
| EPA: ALSEN Sensorion SA | Initiated Coverage: Buy | €1.00 | €0.29 | +241.30% | 1 | Jul 19, 2026 | |
| EPA: SIGHT GenSight Biologics S.A. | Maintained: Hold | €0.08 | €0.09 | -7.94% | 3 | Jul 15, 2026 | |
| IBIO iBio, Inc. | Reiterated: Buy | $5 | $1.40 | +257.14% | 7 | Jul 1, 2026 | |
| PRQR ProQR Therapeutics | Reiterated: Buy | $4 → $3 | $1.97 | +52.28% | 40 | Jun 25, 2026 | |
| SABS SAB Biotherapeutics | Reiterated: Buy | $14 → $16 | $3.77 | +324.40% | 20 | Jun 16, 2026 | |
| BME: PHM Pharma Mar, S.A. | Maintained: Buy | €120.00 → €100.00 | €77.05 | +29.79% | 8 | Jun 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6.5 | $4.01 | +62.09% | 1 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $4.55 | +207.69% | 19 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $11.53 | +30.11% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $27 | $11.21 | +140.86% | 17 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $425 | $228.72 | +85.82% | 51 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $28.03 | +7.03% | 4 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ¥800 | ¥248 | +222.58% | 1 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $4.22 | +373.93% | 12 | Mar 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $2.5 → $45 | $4.19 | +973.99% | 6 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $0.45 | +8,788.89% | 1 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €10.00 → €5.00 | €0.70 | +612.25% | 5 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $85 | $119.23 | -28.71% | 2 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $25 → $6 | $5.01 | n/a | 19 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.24 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 4 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.18 | n/a | 20 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.50 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 | $0.729 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.5 → $5 | $4.62 | n/a | 47 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.80 | n/a | 7 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $8 | $3.01 | n/a | 14 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 13 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $14.96 | n/a | 16 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $16.49 | n/a | 1 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.54 | n/a | 31 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.70 | n/a | 5 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $76.61 | n/a | 6 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.18 | n/a | 18 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.77 | n/a | 1 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $100 → $50 | $0.000001 | n/a | 8 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.51 | n/a | 15 | Sep 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.14 | n/a | 15 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.12 | n/a | 8 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2,174.00 | n/a | 9 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.26 | n/a | 9 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 6 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.26 | n/a | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $4.5 | $1.28 | n/a | 9 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.7252 | n/a | 2 | Nov 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $2 | $5.00 | n/a | 11 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $56.26 | n/a | 1 | Mar 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 2 | Jan 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $21.07 | n/a | 3 | Jun 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.50 | n/a | 1 | Jun 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.3 → $4.5 | $0.7711 | n/a | 3 | Feb 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $2.54 | n/a | 3 | Dec 6, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $1.30 | n/a | 1 | Aug 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.25 | $2.54 | n/a | 1 | Aug 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.25 → $2 | $0.0001 | n/a | 4 | Jul 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $6 | $1.85 | n/a | 4 | Mar 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $1.60 | n/a | 1 | Dec 3, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 | $3.91 | n/a | 1 | Aug 6, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $100 → $18 | $0.0005 | n/a | 3 | May 15, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $3.09 | n/a | 1 | Oct 7, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.5 | $0.000001 | n/a | 1 | Jul 3, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $2.3 | $0.2251 | n/a | 1 | Jun 25, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $45.36 | n/a | 1 | May 16, 2012 |
Arrowhead Pharmaceuticals
Aug 4, 2026
Maintained: Buy
Price Target: $115
Current: $86.91
Upside: +32.32%
Stoke Therapeutics
Aug 3, 2026
Maintained: Buy
Price Target: $35
Current: $31.93
Upside: +9.61%
Dyne Therapeutics
Jul 29, 2026
Maintained: Buy
Price Target: $38
Current: $26.17
Upside: +45.20%
ProMIS Neurosciences
Jul 26, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $13.48
Upside: +48.37%
Sensorion SA
Jul 19, 2026
Initiated Coverage: Buy
Price Target: €1.00
Current: €0.29
Upside: +241.30%
GenSight Biologics S.A.
Jul 15, 2026
Maintained: Hold
Price Target: €0.08
Current: €0.09
Upside: -7.94%
iBio, Inc.
Jul 1, 2026
Reiterated: Buy
Price Target: $5
Current: $1.40
Upside: +257.14%
ProQR Therapeutics
Jun 25, 2026
Reiterated: Buy
Price Target: $4 → $3
Current: $1.97
Upside: +52.28%
SAB Biotherapeutics
Jun 16, 2026
Reiterated: Buy
Price Target: $14 → $16
Current: $3.77
Upside: +324.40%
Pharma Mar, S.A.
Jun 14, 2026
Maintained: Buy
Price Target: €120.00 → €100.00
Current: €77.05
Upside: +29.79%
Jun 10, 2026
Initiated Coverage: Buy
Price Target: $6.5
Current: $4.01
Upside: +62.09%
May 12, 2026
Maintained: Buy
Price Target: $14
Current: $4.55
Upside: +207.69%
May 7, 2026
Reiterated: Buy
Price Target: $15
Current: $11.53
Upside: +30.11%
May 7, 2026
Maintained: Buy
Price Target: $35 → $27
Current: $11.21
Upside: +140.86%
May 1, 2026
Reiterated: Buy
Price Target: $425
Current: $228.72
Upside: +85.82%
Apr 21, 2026
Maintained: Buy
Price Target: $30
Current: $28.03
Upside: +7.03%
Apr 7, 2026
Initiated Coverage: Buy
Price Target: ¥800
Current: ¥248
Upside: +222.58%
Mar 12, 2026
Maintained: Buy
Price Target: $20
Current: $4.22
Upside: +373.93%
Feb 24, 2026
Upgraded: Buy
Price Target: $2.5 → $45
Current: $4.19
Upside: +973.99%
Jan 5, 2026
Maintained: Buy
Price Target: $40
Current: $0.45
Upside: +8,788.89%
Sep 30, 2025
Maintained: Buy
Price Target: €10.00 → €5.00
Current: €0.70
Upside: +612.25%
Sep 25, 2025
Maintained: Buy
Price Target: $60 → $85
Current: $119.23
Upside: -28.71%
May 8, 2025
Downgraded: Hold
Price Target: $25 → $6
Current: $5.01
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $11.24
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $1.18
Upside: n/a
Dec 20, 2024
Rated: Hold
Price Target: n/a
Current: $1.50
Upside: n/a
Dec 20, 2024
Maintained: Hold
Price Target: $12
Current: $0.729
Upside: n/a
Nov 19, 2024
Maintained: Buy
Price Target: $4.5 → $5
Current: $4.62
Upside: n/a
Nov 18, 2024
Reiterated: Buy
Price Target: $6
Current: $1.80
Upside: n/a
Nov 12, 2024
Maintained: Buy
Price Target: $10 → $8
Current: $3.01
Upside: n/a
Mar 14, 2024
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Dec 12, 2023
Rated: Hold
Price Target: n/a
Current: $14.96
Upside: n/a
Mar 9, 2023
Reiterated: Buy
Price Target: n/a
Current: $16.49
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $7.54
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $7.70
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $76.61
Upside: n/a
Feb 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.18
Upside: n/a
Feb 6, 2023
Reiterated: Buy
Price Target: n/a
Current: $9.77
Upside: n/a
Nov 16, 2022
Downgraded: Hold
Price Target: $100 → $50
Current: $0.000001
Upside: n/a
Sep 30, 2022
Rated: Hold
Price Target: n/a
Current: $1.51
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $1.14
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $1.12
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $2,174.00
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $6.26
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Jul 30, 2021
Rated: Hold
Price Target: n/a
Current: $9.26
Upside: n/a
Jun 10, 2021
Reiterated: Hold
Price Target: $8 → $4.5
Current: $1.28
Upside: n/a
Nov 20, 2020
Rated: Hold
Price Target: n/a
Current: $0.7252
Upside: n/a
Jul 30, 2020
Rated: Hold
Price Target: $2
Current: $5.00
Upside: n/a
Mar 23, 2020
Reiterated: Buy
Price Target: n/a
Current: $56.26
Upside: n/a
Jan 28, 2020
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Jun 10, 2019
Rated: Hold
Price Target: n/a
Current: $21.07
Upside: n/a
Jun 10, 2019
Rated: Hold
Price Target: n/a
Current: $7.50
Upside: n/a
Feb 16, 2017
Maintained: Buy
Price Target: $3.3 → $4.5
Current: $0.7711
Upside: n/a
Dec 6, 2016
Maintained: Buy
Price Target: $6
Current: $2.54
Upside: n/a
Aug 23, 2016
Maintained: Buy
Price Target: $4
Current: $1.30
Upside: n/a
Aug 12, 2016
Reiterated: Buy
Price Target: $2.25
Current: $2.54
Upside: n/a
Jul 8, 2016
Maintained: Buy
Price Target: $2.25 → $2
Current: $0.0001
Upside: n/a
Mar 28, 2016
Reiterated: Buy
Price Target: $12 → $6
Current: $1.85
Upside: n/a
Dec 3, 2014
Initiated Coverage: Buy
Price Target: $16
Current: $1.60
Upside: n/a
Aug 6, 2014
Downgraded: Hold
Price Target: $4
Current: $3.91
Upside: n/a
May 15, 2014
Downgraded: Hold
Price Target: $100 → $18
Current: $0.0005
Upside: n/a
Oct 7, 2013
Initiated Coverage: Buy
Price Target: $13
Current: $3.09
Upside: n/a
Jul 3, 2013
Reiterated: Buy
Price Target: $5.5
Current: $0.000001
Upside: n/a
Jun 25, 2013
Initiated Coverage: Buy
Price Target: $2.3
Current: $0.2251
Upside: n/a
May 16, 2012
Initiated Coverage: Buy
Price Target: n/a
Current: $45.36
Upside: n/a